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Abstract
 
Resistance and susceptibility to 
 
Leishmania major
 
 in mice are determined by multiple genes and
correlate with the preferential development of Th1 and Th2 responses, respectively. Here, we
found that CD11b
 
 
 
 dendritic cells (DCs) prime parasite-specific CD4
 
 
 
 T cells in both suscep-
tible BALB/c (H2-d) and resistant B10.D2 (H2-d) mice. However, BALB/c and B10.D2 DCs
from 
 
L. major
 
–infected mice differ in their ability to polarize naive T cells into Th1 or Th2 ef-
fector cells. This difference is cell-intrinsic, is not restricted to H2-d mice, and is observed with
both parasite-specific and allospecific CD4
 
 
 
 T cells. Thus, strain-specific differences within
CD11b
 
 
 
 DCs influence the ability of inbred mice to mount polarized CD4
 
 
 
 T cell responses.
Key words: Ag presentation • T cell differentiation • intracellular pathogen • cytokine secretion • 
 
Leishmania major
 
Introduction
 
Leishmania major
 
 is a protozoan parasite which invades mac-
rophages (1). Most strains of mice, including C57BL/6,
C3H, and B10.D2, develop of a protective Th1 response
and self-healing lesions (1). In contrast, mice of the BALB
genetic background develop a Th2-biased counterprotec-
tive immune response resulting in the development of
progressive lesions and in the dissemination of the parasite
to internal organs. Because BALB/c (H2-d) and B10.D2
(H2-d) mice differ in several polymorphic genes which
control resistance to 
 
L. major
 
, elucidating how these genes
work should provide valuable information on the mecha-
nisms leading to differentiation of naive T cells. Suscepti-
bility to 
 
L. major
 
 is a multigenic phenotype which depends
on several genetic loci (2–5). Candidate loci were identi-
fied on chromosomes 6, 7, 10, 11, 15, and 16 (2). The
presence of all six loci is not necessary to confer resistance
and no single locus is required. Rather, various combina-
tions of these loci are capable of conferring resistance. Fur-
thermore, both T cell and non-T cell compartment can in-
dependently determine resistance to 
 
L. major
 
 (6). Thus,
several genes are impaired in BALB strains and the accu-
mulation of these defects results in susceptibility to 
 
L. major
 
.
Previous studies have shown that T cells from BALB/c
mice are intrinsically different from those of other strains
(7–10). For example, BALB/c T cells exhibit an intrinsic
ability to secrete high amounts of IL-4 and to rapidly lose
IL-12 responsiveness in vitro
 
.
 
 However, it is not known
whether this latter phenomenon accounts for the impaired
ability of BALB/c mice to mount a Th1 protective re-
sponse upon infection with 
 
L. major
 
. During the course of
 
L. major
 
 infection, Langerhans cells (LCs)
 
*
 
 transport 
 
L. ma-
jor
 
 promastigotes from the skin to the draining LN (11–13).
Ingestion of 
 
L. major
 
 amastigotes by LC-like immature
DCs derived from fetal skin results in the up-regulation of
CD80, CD86, CD40, ICAM-1, and MHC class II mole-
cules (14, 15). However, it is not known whether DCs
from different mouse strains differ in their ability to pro-
mote the differentiation of naive CD4
 
 
 
 T cells into Th1 or
Th2 effector cells. To address this issue, we have infected
mice with 
 
L. major
 
 and purified DCs from their draining
LN. By comparing the ability of these cells to induce the
differentiation of naive TCR transgenic CD4
 
 
 
 T cells
which are specific for the 
 
L. major
 
 LACK Ag, we have dis-
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Abbreviations used in this paper:
 
 LC, Langerhans cell; SLA, soluble 
 
Leishma-
nia
 
 antigens.T
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covered an intrinsic difference in DCs from BALB/c versus
B10.D2 mice.
 
Materials and Methods
 
Mice and Parasites.
 
BALB/c and B10.D2 mice were purchased
from Harlan. 16.2
 
 
 
 (16) and WT15 (17) transgenic mice have
been previously described. Animals were housed under SPF con-
ditions and used between 7 and 10 wk of age. 
 
L. major
 
 promasti-
gotes (World Health Organization strain WHOM/IR/-/173)
were grown in M199 medium containing 20% FCS. Mice were
infected with 2 
 
 
 
 10
 
6
 
 stationary phase promastigotes as described
(18). In some experiments, BALB/c mice were injected i.p. with
200 ng of recombinant murine IL-1
 
 
 
 1 d before infection, at the
time of infection, and 2 d later. Parasite loads were measured as
described (19). All experiments were performed in compliance
with the CNRS institutional guidelines and have been approved
by the local committee for animal experimentation.
 
Reagents and Antibodies.
 
The following mAb were purchased
from Becton Dickinson: GK1.5, anti-CD4; 53–6.7, anti-CD8
 
 
 
;
KT4.1, anti-V
 
 
 
4; RA3–6B2, anti-B220; 2G9; anti-I-A
 
d
 
/I-E
 
d
 
;
M1/70, anti-CD11b; HL3, anti-CD11c; 1G10, anti-CD80; GL1,
anti-CD86; 3/23, anti-CD40; 145–2C11, anti-CD3. Recombi-
nant murine IL-1
 
 
 
, IFN-
 
 
 
, IL-2, IL-4, and IL-5 were purchased
from R&D Systems. LACK peptide (aa 158 through 173:
FSPSLEHPIVVSGSWD) was synthesized by Mimotopes France.
 
Cells.
 
LMR7.5 hybridomas express a high affinity TCR spe-
cific for the LACK peptide (aa 158 through 163) bound to I-A
 
d
 
MHC class II molecules (16). To prepare DCs, LNs were di-
gested with a cocktail of DNase I fraction IX (Sigma-Aldrich;
100 
 
 
 
g/ml) and 1.6 mg/ml of collagenase (400 Mandl U/ml) at
37
 
 
 
C for 45 min. DCs were positively selected by MACS using
N418 (anti-CD11c) magnetic beads (Miltenyi Biotec) in the
presence of 10% mouse serum and 5 mM EDTA according to the
manufacturer instructions. Positively selected cells were pure to
more than 95% as determined by flow cytometry analysis follow-
ing staining with anti-CD11c mAb. Cells were either used im-
mediately, or further sorted by flow cytometry into CD11b
 
 
 
CD11c
 
 
 
 and CD11b
 
 
 
 CD11c
 
 
 
 subsets after staining with anti-
CD11b and anti-CD11c mAb. In some experiments, LN cells
were depleted of CD3
 
 
 
 cells using Dynabeads (Dynal) prior puri-
fication of CD11c
 
 
 
 cells. Bone marrow–derived DCs were pre-
pared as described (20). CD4
 
 
 
 LN cells were purified by negative
depletion of CD8
 
 
 
, B220
 
 
 
, CD11b
 
 
 
, and I-A
 
d
 
 
 
 cells using sheep
anti-rat Ig-coated Dynabeads (Dynal). Naive CD44
 
low
 
 CD62L
 
high
 
CD4
 
 
 
 T cells were further purified by flow cytometry.
 
T Cell Assays.
 
For stimulation of T cell hybridomas,
CD11c
 
 
 
 cells or purified subsets of DCs were incubated with 10
 
5
 
LMR7.5 hybridomas with or without 1 
 
 
 
M of LACK peptide, in
DMEM supplemented with 
 
l
 
-glutamine (2 mM), heat-inacti-
vated FCS (10%), 2-ME (5 
 
 
 
 10
 
 
 
5
 
 M), penicillin (100 
 
 
 
g/ml),
and streptomycin (100 U/ml) in U-bottomed 96-well plates. Su-
pernatants were harvested 24 h later and IL-2 contents were mea-
sured by ELISA. For stimulation of TCR transgenic T cells, DCs
were incubated with 5 
 
 
 
 10
 
5
 
 CD44
 
low
 
 CD62L
 
high
 
 CD4
 
 
 
 cells
from F1 (BALB/c 
 
 
 
 B10.D2) WT15 or 16.2
 
 
 
 transgenic mice
with the indicated concentrations of LACK peptide in U-bot-
tomed 96-well plates or flat-bottomed 48-well plates. Superna-
tants were harvested on day 3 or 6 and analyzed for IFN-
 
 
 
, IL-4,
and IL-5 contents by ELISA. When indicated, T cells were puri-
fied and restimulated with 1 
 
 
 
M of LACK peptide in the pres-
ence of 2 
 
 
 
 10
 
6
 
 mitomycin C-treated splenocytes from F1
(BALB/c 
 
 
 
 B10.D2) mice. For stimulation of T cells from in-
fected mice, 5 
 
 
 
 10
 
5
 
 purified CD4
 
 
 
 T cells were incubated with
2 
 
 
 
 10
 
6
 
 mitomycin C–treated syngeneic splenocytes with or
without 30 
 
 
 
g/ml of soluble 
 
Leishmania
 
 antigens (SLA) in flat-
bottomed 96-well plates. Supernatants were harvested 48 h later
and analyzed for IFN-
 
 
 
, IL-4, and IL-5 contents by ELISA. For
intracellular staining of cytokines, cells were incubated for 4 h at
37
 
 
 
C with PMA (10 ng/ml), ionomycin (1.5 
 
 
 
g/ml), and brefel-
din A (10 
 
 
 
g/ml). Cells were fixed and permeabilized using the
Cytofix/Cytoperm kit (BD Biosciences) and stained with anti–
IL-4 and anti–IFN-
 
 
 
 mAb.
 
Real-Time RT-PCR.
 
Total RNA from CD11c
 
 
 
 or CD11b
 
 
 
CD11c
 
 
 
 cells was extracted and reverse transcribed as described
(21). Complementary DNA was quantitatively analyzed for the
expression of murine cytokines (IFN-
 
 
 
, GM-CSF, IFN-
 
 
 
, IL-12
p35, IL-12 p40, IL-3, IL-4, IL-6, IL-1
 
 
 
, IL-1
 
 
 
, TNF-
 
 
 
, IL-10,
TGF-
 
 
 
1, TGF-
 
 
 
2, and TGF-
 
 
 
3), 18S ribosomal RNA and
ubiquitin mRNA, using the fluorogenic 5
 
 
 
-nuclease PCR assay
(22) as described (21). Specific primers were obtained from
DNAX. Gene-specific PCR products were continuously mea-
sured by means of an ABI PRISM 5700 Sequence Detection Sys-
tem (Applied Biosystems) during 40 cycles. Ubiquitin mRNA
was used for normalization.
 
Flow Cytometry.
 
Cells were analyzed by flow cytometry using
a FACSCalibur™ and the CELLQuest™ software (Becton Dick-
inson). Cell sorting was performed using a FACSVantage SE™
(Becton Dickinson). In some experiments, positively selected
CD11c
 
 
 
 cells were incubated on ice for 30 min with anti-CD8
 
 
 
,
anti-CD11b, anti-CD11c mAb, and either anti-CD80, or anti-
CD86, anti-I-A
 
d
 
, or anti-CD40 mAb. Staining was performed in
PBS containing 0.5% BSA.
 
Results
 
MHC Class II Presentation of LACK In Vivo.
 
Infection
of BALB/c and B10.D2 mice with 
 
L. major
 
 induces
LACK-specific CD4
 
 
 
 T cells to up-regulate CD69 and
CD44 and to progress through the cell cycle (16). Acti-
vated LACK-specific CD4
 
 
 
 T cells are first detected in the
draining LN and their frequency peaks at day 3, suggesting
that APCs that have captured and processed LACK are
present in the LN on day 2. As DCs have been shown to
be responsible for the priming of CD4
 
 
 
 T cells in some ex-
perimental models (23–25), we sought to investigate the
role of DCs in the priming of parasite-specific CD4
 
 
 
 T
cells. To this aim, CD11c
 
 
 
 and CD11c
 
 
 
 cells were purified
from the draining LN of BALB/c and B10.D2 mice which
had been infected 2 d earlier with 
 
L. major
 
. We next incu-
bated these cells with LACK-specific LMR7.5 T cell hy-
bridomas with or without LACK peptide. In the absence of
peptide, CD11c
 
 
 
 cells, but not CD11c
 
 
 
 cells, induced
LMR7.5 hybridomas to secrete IL-2 in a dose-dependent
manner (Fig. 1). In contrast, both CD11c
 
 
 
 and CD11c
 
 
 
cells stimulated LMR7.5 hybridomas when incubated
with LACK peptide. Thus, although both CD11c
 
  and
CD11c  cells can present LACK to T cells in vitro, only
CD11c  cells do so in vivo.
Polarization of CD4  T Cells by BALB/c or B10.D2
DCs. Previous studies have shown that CD4  T cells
from infected BALB/c and B10.D2 mice secrete different
amounts of IFN- , IL-5, and IL-4 when restimulated withT
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SLA. Likewise, in a typical experiment, LN CD4  T cells
from BALB/c mice secreted 10- to 20-fold less IFN-  than
those from B10.D2 mice (Fig. 2 A). In contrast, while T
cells from BALB/c mice secreted relatively high amounts of
IL-4 and IL-5, these cytokines were below the levels of de-
tection in the wells containing B10.D2 T cells. To investi-
gate whether DCs could induce the differentiation of naive
LACK-specific CD4  T cells in vitro, we used WT15
TCR transgenic mice in which CD4  T cells express the  
and   chains of a high avidity LACK-specific TCR (17).
We incubated LN CD11c  cells from infected BALB/c or
B10.D2 mice with naive CD4  T cells from F1 (BALB/c  
B10.D2) WT15 transgenic mice with or without LACK
peptide, and analyzed supernatants for cytokine contents on
day 3 and 6, respectively. In the absence of peptide, B10.D2
DCs induced WT15 transgenic T cells to secrete twofold
more IFN-  and fourfold less IL-5 than BALB/c DCs (Fig.
2 B, left panel). While the levels of IL-5 and IFN-  varied
from one experiment to another, the IL-5/IFN-  ratio was
5.8     0.7-fold higher when T cells were primed with
BALB/c DCs as compared with B10.D2 DCs (P   0.05).
We obtained qualitatively similar results when T cells were
stimulated with LACK peptide (Fig. 2 B, right panel). IL-4
secretion was below the limit of detection in all samples. T
cells did not secrete any detectable amounts of IL-5 and
IFN-  when incubated without DCs (unpublished data). 
To generalize this phenomenon to polyclonal popula-
tions of T cells, we used 16.2  single chain transgenic mice
which exhibit both an increased frequency of LACK-spe-
cific T cells and a polyclonal T cell repertoire as the result
of the transgenic expression of the   chain of a LACK-spe-
cific hybridoma (16). In the absence of LACK peptide, na-
ive CD4  T cells from F1 (BALB/c   B10.D2) 16.2 
transgenic mice secreted fourfold more IFN-  and twofold
less IL-5 when incubated with B10.D2 DCs than when in-
cubated with BALB/c DCs (Fig. 2 C, left). To confirm
that the effector T cells which were generated in these ex-
periments secreted different amounts of Th1 and Th2 cyto-
kines, live cells were recovered after primary stimulation
and further incubated for 2 d with LACK peptide and
mitomycin C–treated splenocytes from F1 (BALB/c  
B10.D2) mice. As observed in primary cultures, T cells
which had been primed with BALB/c DCs secreted more
Figure 1. MHC class II presentation of LACK by CD11c  cells.
BALB/c (left panels) and B10.D2 (right panels) mice were infected with
L. major promastigotes into the hind footpads. LN cells were prepared on
day 2 and depleted of CD3  cells. Cells were either used directly ( ) or
sorted into CD11c  ( ) and CD11c  ( ) cells. The indicated numbers
of cells were incubated with 105 LMR7.5 hybridomas without (top pan-
els) or with (bottom panels) 1  M of LACK peptide. Supernatants were
harvested 24 h later and analyzed for IL-2 content. Data are representative
of five experiments.
Figure 2. DCs from infected BALB/c and B10.D2 mice
differ in their ability to polarize naive CD4  T cells.
BALB/c ( ) and B10.D2 ( ) mice were infected with L.
major. (A) LN CD4  T cells were purified 5 wk after infec-
tion and 5   105 cells were incubated with SLA (30  g/
ml) and 2   106 mitomycin C–treated syngeneic spleno-
cytes. Supernatants were analyzed after 48 h for IFN- , IL-5,
and IL-4 contents by ELISA. Data show the amounts of
IFN-  (ng/ml), IL-5 (U/ml), and IL-4 (ng/ml). (B and C)
LN CD11c  cells were purified on day 2. (B) CD44low
CD62Lhigh CD4  T cells were purified from F1 (BALB/c  
B10.D2) WT15 transgenic mice and 5   105 cells were
incubated with 1.2   105 CD11c  cells without (left panel)
or with (right panel) 1  M of LACK peptide. Supernatants
were harvested on day 6 (left panel) or on day 3 (right
panel) and analyzed for IFN-  and IL-5 contents. Data are
representative of six experiments and show the amounts of
IFN-  (ng/ml) and IL-5 (U/ml). (C) CD44low CD62Lhigh
CD4  T cells were purified from F1 (BALB/c   B10.D2)
16.2  transgenic mice and 1.5   106 cells were incubated
with 3   105 CD11c  cells without LACK peptide. (left)
Supernatants were harvested on day 6 and analyzed for
IFN-  and IL-5 contents. Live cells were purified and re-
stimulated with mitomycin C–treated F1 splenocytes and 1
 M of LACK peptide. (right) Supernatants were harvested
on day 3 and analyzed for IFN- , IL-4, and IL-5 contents.
Data are representative of three experiments and show the
amounts of IFN-  (ng/ml), IL-5 (U/ml), and IL-4 (ng/ml).T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
204 T Cell Polarization by Dendritic Cells
IL-5 and less IFN-  than those which had been primed
with B10.D2 DCs. Furthermore, while IL-4 was below the
level of detection in primary cultures, T cells which had
been primed with BALB/c DCs secreted 8- to 10-fold
more IL-4 than those which had been primed with B10.D2
DCs (Fig. 2 C, right panel).
LACK Is Presented by CD11b  DCs In Vivo. LN CD11c 
cells have been classified into CD11b CD8  , CD11b 
CD8  , and CD11b CD8   cells (26). To identify which
DCs are responsible for the activation of LACK-specific
T cells in vivo, we purified CD11b  and CD11b  DCs
from the LN of infected mice and incubated various num-
bers of these cells with LMR7.5 hybridomas. In the ab-
sence of LACK peptide, CD11b  DCs were 1,000- to
10,000-fold more efficient than CD11b  DCs in stimulat-
ing LMR7.5 hybridomas to secrete IL-2 (Fig. 3 A). In con-
trast, both cell types were equally efficient in stimulating
LMR7.5 hybridomas when incubated with LACK peptide.
We obtained similar results using BALB/c and B10.D2
DCs. Thus, while both CD11b  and CD11b  DCs could
present LACK peptide to CD4  T cells in vitro, CD11b 
DCs were solely responsible for the priming of LACK-
specific T cells in vivo.
We next investigated whether strain-specific differences
within CD11b  DCs accounted for the ability of B10.D2
and BALB/c DCs to differentially polarize naive CD4  T
cells in vitro. CD11b  and CD11b  DCs were purified
from the LN of infected BALB/c and B10.D2 mice, and
these cells or mixtures of these cells were incubated with
naive F1 WT15 TCR transgenic T cells. While WT15
TCR transgenic T cells did not secrete any detectable
amount of IFN-  or IL-5 after incubation with CD11b 
DCs (unpublished data), these T cells secreted twofold
more IFN-  and 10-fold less IL-5 when primed with
CD11b  DCs from B10.D2 mice as compared with
CD11b  DCs from BALB/c mice (Fig. 3 B). Further ex-
periments using mixtures of CD11b  and CD11b  DCs
showed that CD11b  DCs had little effect on T cell polar-
ization, further confirming that the amounts of IFN-  and
IL-5 which were secreted by T cells were mainly deter-
mined by CD11b  DCs.
Several parameters influence the differentiation of naive
CD4  T cells, including the dose of Ag, the nature and the
amounts of cytokines in the extracellular medium, and the
levels of accessory molecules expressed by APCs (27). To
determine whether BALB/c and B10.D2 DCs expressed
different amounts of cytokine mRNA, we purified CD11b 
CD11c  cells from infected mice on day 0 and day 2 after
infection. We next measured cytokine mRNA levels using
real time RT-PCR. CD11b  DCs from infected B10.D2
mice expressed 10- to 15-fold more IL-1  mRNA than
those from infected BALB/c animals (Fig. 4 A). CD11b 
DCs from naive B10.D2 mice also expressed more IL-1 
mRNA than those from naive BALB/c mice. All other cy-
tokine mRNA, including those coding for IFN- , GM-
CSF, IFN- , IL-12 p35, IL-12 p40, IL-6, IL-1 , TNF- ,
TGF- 1, and TGF- 2 mRNA were expressed at similar
levels by CD11b  DCs in the two strains before and after
Figure 3. MHC class II presentation of LACK by
CD11b  DCs. BALB/c (left panels) and B10.D2 (right
panels) mice were injected with L. major promastigotes
into the hind footpads. LN cells were prepared on day 2
and depleted of CD3  cells. CD11c  cells were purified
by MACS and stained with anti-CD11b and anti-CD11c
mAb. (A) CD11b  ( ) and CD11b  ( ) DCs were sorted
by flow cytometry, and the indicated numbers of cells
were incubated with 105 LMR7.5 hybridomas without
(top panels) or with (bottom panels) 1  M of LACK pep-
tide. Supernatants were harvested 24 h later and analyzed
for IL-2 content. Data are representative of five experi-
ments. (B) CD11b  and CD11b  DCs were sorted by
flow cytometry, and mixtures of these cells (6   104 cells
of the indicated subset), or 1.2   105 CD11b  cells alone,
were incubated with 5   105 CD44low CD62Lhigh CD4 
T cells from F1 (BALB/c   B10.D2) WT15 transgenic
mice. Supernatants were harvested on day 6 and analyzed
for IFN-  (white bars) and IL-5 (black bars) contents. The
IL-5/IFN-  ratio (gray bars) was calculated for each sam-
ple. Data are representative of three experiments.T
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infection. IL-3, IL-4, IL-10, and TGF- 3 mRNA were be-
low the level of detection in all samples (unpublished data).
T cell activation is induced by the simultaneous engage-
ment of the costimulatory molecule CD28 expressed on T
cells with its ligands CD80 and CD86 expressed at the sur-
face of APCs (28). Some investigators have suggested that
CD80 and CD86 provide similar costimulatory signals for
T cell proliferation, cytokine production, and generation
of CTLs (29). However, others have reported significant
biological differences between these molecules, including
differences in their ability to induce maturation toward
polarized Th1 or Th2 effector cells (30). To measure the
levels of expression of CD80 and CD86 at the surface of
CD11b  DCs, we purified LN DCs from BALB/c and
B10.D2 mice on day 0 and 2 after infection and analyzed
these cells by flow cytometry after staining with anti-
CD11b and anti-CD11c mAb, and mAb to CD80, CD86,
CD40, and I-Ad MHC class II molecules. CD11b  DCs
from naive B10.D2 mice expressed 1.5- to 2-fold more
CD80 than those from naive BALB/c mice (Fig. 4 B).
Furthermore, while CD80 was only slightly and tran-
siently up-regulated by L. major in BALB/c mice, its level
of expression was increased by 2.5   0.6-fold in B10.D2
animals. In both BALB/c and B10.D2 mice, L. major in-
duced the down-regulation of CD86 and the up-regula-
tion of CD40 and I-Ad. However, in contrast to CD80,
CD11b  DCs from BALB/c and B10.D2 mice expressed
roughly similar levels of CD86, CD40, and I-Ad before as
well as 1, 2, and 3 d after infection (Fig. 4, B and C, and
unpublished data).
IL-1  Inhibits the Development of Th2 Cells In Vivo. To
determine whether IL-1  could have an effect on the polar-
ization of parasite-specific T cells in the setting of L. major
infection, BALB/c mice were treated or not with recombi-
nant murine IL-1  and infected with L. major together with
control B10.D2 mice. Mice were killed 5 wk later and para-
site loads were measured by limiting dilution (Fig. 5 A).
While untreated BALB/c mice exhibited 6   2.7   109
parasites in their LN, parasite loads in B10.D2, and IL-1 -
treated BALB/c mice were 4.6   2.0   104 and 2.1   1  
108, respectively. In parallel experiments, LN cells were ana-
lyzed by flow cytometry after intracellular staining of IFN- 
and IL-4 (Fig. 5 B). While 5.1   0.8% of CD4  T cells se-
creted IFN-  in B10.D2 mice, the frequency of IFN- –
secreting CD4  T cells was 2.0   0.2% in both IL-1 –treated
and untreated BALB/c mice. In contrast, the frequency of
IL-4–secreting CD4  T cells was 2.1   0.3% in untreated
BALB/c mice, as compared with 1.0   0.2% and 0.4  
0.1% in IL-1 –treated mice and B10.D2 mice, respectively.
Thus, treatment of BALB/c mice with IL-1  resulted in a
significantly reduced Th2 response (P   0.02) and in a 20-
fold reduction in the number of parasites in the draining LN.
BALB/c and B10.D2 DCs Are Intrinsically Different. To
determine whether the differential ability of BALB/c and
B10.D2 DCs to polarize CD4  T cells was the result of L.
major infection or was an intrinsic property of these DCs,
we incubated LN DCs from naive mice with naive CD4 
T cells from F1 WT15 transgenic mice and different
amounts of LACK peptide, and analyzed supernatants for
IFN-  and IL-5 contents on day 3. At low or intermediate
Figure 4. Cytokine mRNA
and costimulatory molecules ex-
pressed by BALB/c and B10.D2
DCs. Mice were infected or not
with L. major promastigotes. (A)
LNs were harvested on day 2
and CD11b  CD11c  cells were
purified by flow cytometry.
mRNA levels for the indicated
cytokines were measured using
Real Time RT-PCR. Values are
expressed as the number of Ct
for each cytokine mRNA af-
ter normalization to ubiquitin
mRNA for infected BALB/c
(white bars) and B10.D2 (black
bars) mice, and for PBS-injected
BALB/c (light gray bars) and
B10.D2 (dark gray bars) mice.
Data are representative of three
experiments. (B and C) LN
CD11c  were purified at the in-
dicated times after infection and
cells were analyzed by flow cy-
tometry after staining with anti-
CD11b, anti-CD11c, and either
anti-CD80, anti-CD86, anti-
CD40, or anti-I-Ad mAb. (B)
Typical flow cytometry profiles
are shown after gating on CD11b  DCs for BALB/c (thin lines) and B10.D2 (thick lines) mice. Data show the mean fluorescence intensity (MFI) ex-
pressed as geometric mean for BALB/c (plain) and B10.D2 (bold) mice. (C) Surface levels of CD80 (left panel) and CD86 (right panel) were measured at
the indicated times after infection in BALB/c ( ) and B10.D2 ( ) mice. Data show MFI expressed as geometric mean.T
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peptide concentrations ( 200 nM), the IL-5/IFN-  ratio
was two- to threefold higher for BALB/c than for B10.D2
DCs (Fig. 6 A). While the levels of cytokines produced var-
ied from one experiment to another, the IL-5/IFN-  ratio
at 50 nM of LACK peptide was 3.4   0.6-fold higher
when T cells were primed with BALB/c DCs as compared
with B10.D2 DCs (P   0.05). Similar results were obtained
using bone marrow-derived DCs (Fig. 6 B). Thus, the dif-
ferential ability of BALB/c and B10.D2 DCs to polarize
CD4  T cells in vitro was an intrinsic property of these cells
rather than the result of L. major infection. To determine
whether differences found in the amounts of cytokines pro-
duced resulted from differences in the frequencies of cyto-
kine-secreting cells, we incubated LN DCs from naive
BALB/c and B10.D2 mice with naive CD4  T cells from
F1 WT15 transgenic mice and an intermediate amount of
LACK peptide (50 nM). Cells were then restimulated with
an optimal amount of LACK peptide in the presence of
syngeneic splenocytes, and cellular supernatants were ana-
lyzed for cytokine contents by ELISA. Alternatively, cells
were restimulated with PMA and ionomycin and further
analyzed by flow cytometry for intracellular staining of
IFN- , IL-4, and IL-5. Upon restimulation, T cells primed
with DCs from naive BALB/c mice secreted more IL-4 and
IL-5 and less IFN-  than those primed with DCs from na-
ive B10.D2 mice (Fig. 6 C). While IL-4- and IL-5–secret-
ing T cells were hardly detectable in all samples, the fre-
quency of IFN- –secreting T cells was three- to fourfold
higher upon priming with B10.D2 DCs as compared with
BALB/c DCs (24.6 versus 8.4% in a typical experiment).
Qualitatively similar results were obtained when cells were
restimulated with anti-CD3 mAb (unpublished data).
We next investigated whether BALB/c and B10.D2
DCs differed in their ability to polarize allospecific CD4 
T cells. To this aim, LN CD11c  cells from naive BALB/c
or B10.D2 mice were incubated with naive CD4  T cells
Figure 5. Effect of IL-1  on T cell polarization and parasite load.
BALB/c mice (five mice per group) were treated or not with recombi-
nant murine IL-1  and infected with L. major, together with control
B10.D2 mice. Mice were killed 5 wk later. (A) Parasite loads were mea-
sured in draining LN. Data show mean   SEM for untreated BALB/c
mice (empty bars), IL-1 –treated BALB/c mice (dashed bars), and
B10.D2 mice (filled bars). (B) LN cells were stimulated with PMA and
ionomycin, and further analyzed by flow cytometry after surface staining
with anti-CD4 mAb and intracellular staining with anti-IL-4 and anti-
IFN-  mAb. Data show representative FACS® profiles after gating on
CD4  T cells (top panels), and the frequency of IL-4– and IFN- –secret-
ing cells (mean   SEM) for untreated BALB/c mice (empty bars), IL-1 -
treated BALB/c mice (dashed bars), and B10.D2 mice (filled bars; bottom
panels). Statistical analysis was performed using Student’s t test.
Figure 6. DCs from naive BALB/c and B10.D2 mice differ in their
ability to polarize CD4  T cells. CD11c  cells were purified from the
popliteal LNs (A and C) or generated from the bone marrow (B) of naive
BALB/c ( ) and B10.D2 ( ) mice. 2   105 cells were pulsed for 18 h
with the indicated concentrations (A and B) or 50 nM (C) of LACK pep-
tide, and further incubated with 5   105 CD44low CD62Lhigh CD4  T
cells from F1 (BALB/c   B10.D2) WT15 TCR transgenic mice. (A and
B) Supernatants were harvested on day 3 and analyzed for IFN-  and IL-5
contents. Data are representative of six and three experiments, respec-
tively, and show the ratios between IL-5 (U/ml) and IFN-  (ng/ml). (C)
Cells were recovered on day 3 and restimulated with 2  M of LACK
peptide in the presence of syngeneic splenocytes. Supernatants were ana-
lyzed on day 3 for IFN- , IL-4, and IL-5 contents (left panels). Data
show the amounts of IFN-  (ng/ml), IL-5 (U/ml), and IL-4 (ng/ml).
Cells were restimulated with PMA and ionomycin, stained with anti-
CD4 mAb and analyzed by flow cytometry for intracellular staining of
IFN-  and IL-4 (right panels). Data are representative of three experi-
ments and show FACS® profiles after gating on CD4  T cells.T
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207 Filippi et al.
from either C3H (H2-k) or C57BL/6 (H2-b) mice. What-
ever DC numbers were used, IL-5/IFN-  ratios were two-
to eightfold higher for BALB/c DCs than for B10.D2 DCs
(Fig. 7 A). Similar results were obtained using naive T cells
from C57BL/6 mice (Fig. 7 B). To investigate whether the
differential ability of BALB/c and B10.D2 DCs to polarize
CD4  T cell responses could be observed with DCs ex-
pressing other MHC molecules, we incubated LN CD11c 
cells from BALB.B (H2-b) and C57BL/6 (H2-b) mice
with naive CD4  T cells from C3H (H2-k) mice. As ob-
served with BALB/c and B10.D2 DCs, T cells incubated
with BALB.B DCs secreted more IL-5 and less IFN-  than
those incubated with C57BL/6 DCs (Fig. 7 C).
Discussion
Previous studies have shown that L. major promastigotes
are transported from the inflammatory site to the LN by
LCs (12) and that LN DCs from infected mice are capable
of stimulating parasite-specific T cells in vitro (13). How-
ever, it was not known whether parasite Ag are processed
by other types of cells in vivo. Furthermore, despite the
characterization of several L. major Ag, no study had been
performed to identify the APCs which are responsible for
the processing of defined parasite Ag and their presentation
to CD4  T cells. Lastly, although many subsets of DCs
have been described (26), it was not known whether all
DCs present Ag to T cells in vivo or whether this task is
performed by a restricted subset of DCs. To address these
issues, we used LMR7.5 T cell hybridomas which express a
TCR exhibiting a high avidity for a LACK-derived pep-
tide bound to I-Ad. In both infected BALB/c and B10.D2
mice, CD11c , but not CD11c  cells stimulated LMR7.5
hybridomas. Furthermore, CD11b  DCs were far more
efficient than CD11b  DCs in stimulating LMR7.5 hy-
bridomas. However, CD11b  DCs were as efficient as
CD11b  DCs in stimulating LMR7.5 hybridomas when
incubated with LACK peptide. Thus, while both CD11b 
and CD11b  DCs can present LACK to CD4  T cells in
vitro, CD11b  DCs are solely responsible for the priming
of LACK-specific CD4  T cells in vivo, at least 2 d after
infection. It remains to be determined whether this remains
true during the late stages of the disease, and whether
CD11b  DCs also stimulate CD4  T cells reacting to other
parasite Ag. It would also be interesting to determine
whether CD11b  DCs are responsible for the stimulation
of CD4  T cells when LACK is not delivered upon infec-
tion with L. major. In this respect, we have recently found
that LN CD11b  DCs are responsible for the tolerization
of islet-specific CD4  T cells in NOD mice in which  
cell apoptosis has been induced (31). Likewise, Zhao and
colleagues have found that only CD11b  submucosal DCs
present viral Ag to CD4  T cells in mice which have been
infected with Herpes Simplex Virus (HSV)-2 (32). Thus,
while other APCs have the ability to present antigenic pep-
tides in vitro, it seems that CD11b  DCs play a critical role
in the priming of CD4  T cells in vivo, at least when these
T cells react to cell-associated Ag.
Although CD11b  DCs were responsible for the prim-
ing of CD4  T cells in both B10.D2 and BALB/c mice,
naive CD4  T cells secreted more IFN-  and less IL-5
when incubated with B10.D2 DCs as compared with
BALB/c DCs. This was observed using both unseparated
CD11c  and purified CD11b  DCs, suggesting that strain-
specific differences within the CD11b  DC subset are suf-
ficient to influence the differentiation of CD4  T cells. We
obtained similar results with DCs from naive mice incu-
bated with either LACK-specific TCR transgenic T cells
and LACK peptide, or allospecific CD4  T cells from C3H
or C56BL/6 mice. Likewise, CD4  T cells from C3H
mice secreted more IL-5 and less IFN-  when incubated
with BALB.B DCs as compared with C57BL/6 DCs.
Thus, the preferential ability of B10.D2 and BALB/c DCs
to polarize CD4  T cells into Th1 or Th2 effector cells, re-
spectively, is an intrinsic property of these DCs, is not de-
pendent on L. major infection, is not restricted to mice of
Figure 7. DCs from different strains of mice differ in their ability to po-
larize allospecific CD4  T cells. (A and B) CD11c  cells were purified
from the popliteal LN of naive BALB/c ( ) or B10.D2 ( ) mice and the
indicated numbers of cells were incubated with 5   105 CD44low
CD62Lhigh CD4  T cells from C3H (A) or C57BL/6 (B) mice. Superna-
tants were harvested on day 3 and analyzed for IFN-  and IL-5 contents.
Data are representative of four experiments and show the ratios between
IL-5 (U/ml) and IFN-  (ng/ml). (C) CD11c  cells were purified from
the popliteal LN of naive BALB.B ( ) or C57BL/6 ( ) mice and the in-
dicated numbers of cells were incubated with 5   105 CD44low CD62Lhigh
CD4  T cells from C3H mice. Supernatants were harvested on day 3 and
analyzed for IFN-  and IL-5 contents. Data show the ratios between IL-5
(U/ml) and IFN-  (ng/ml) in a representative out of two experiments.T
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the H2-d haplotype, and can be observed with both
LACK-specific and allospecific CD4  T cells.
It remains to be elucidated why DCs from different
strains differ in their ability to polarize naive CD4  T cells
into cytokine-secreting cells. Previous studies have shown
that the Ag dose influences the differentiation of naive
CD4  T cells (27). We found that LN DCs from infected
BALB/c and B10.D2 mice expressed similar levels of
I-Ad MHC class II molecules. Furthermore, B10.D2 and
BALB/c DCs pulsed with relatively high amounts of
LACK peptide retained their preferential ability to polarize
naive T cells into Th1 and Th2 effector cells, respectively.
Thus, the differential ability of BALB/c and B10.D2 DCs
to polarize naive CD4  T cells did not reflect possible dif-
ferences in the amounts of peptide/MHC complexes ex-
pressed at the cell surface. Several pathogens induce DCs to
secrete polarizing cytokines such as IL-12 (33). However,
in contrast to other pathogens and to L. major amastigotes,
L. major promastigotes evade IL-12 induction (34). In
agreement with this latter study, L. major promastigotes did
not induce DCs to up-regulate IL-12 p35 or p40 mRNA.
Furthermore, many cytokine mRNA, including those cod-
ing for IFN- , GM-CSF, IFN- , IL-6, IL-1 , TNF- ,
TGF- 1, and TGF- 2, were expressed at similar levels in
BALB/c and B10.D2 DCs both before and after infection.
Thus, as previously suggested (34), infection with L. major
promastigotes is rather silent at least in the draining LN on
day 2. In contrast to other cytokine mRNA, CD11b  DCs
from B10.D2 mice expressed significantly more IL-1 
mRNA than those from BALB/c animals both before and
after infection. Although it remains to be determined
whether there is a causal relationship between this latter
phenomenon and the differential ability of B10.D2 and
BALB/c DCs to polarize T cell responses, it is noteworthy
that mice deficient for the IL-1 type I receptor (IL-1RI)
exhibit reduced Th1 and increased Th2 responses upon in-
fection with L. major (35). Furthermore, we have shown
here that BALB/c mice treated with recombinant IL-1  at
the time of infection developed a decreased Th2 response
and exhibited less parasites than untreated BALB/c mice.
Thus, the fact that CD11b  DCs from B10.D2 mice ex-
pressed more IL-1  mRNA than those from BALB/c mice
may be one of the parameters accounting for the increased
ability of B10.D2 DCs to promote Th1 responses. We
have also found that CD11b  DCs from B10.D2 mice ex-
pressed more CD80 than those from BALB/c mice. As in-
teractions between CD80 and CD28 have been shown to
promote the development of Th1 cells and to down-regu-
late Th2 responses (30), it is also possible that the differen-
tial expression of CD80 by BALB/c and B10.D2 DCs may
contribute to their differential ability to polarize T cells.
Despite a large body of evidence showing that BALB/c
(H2-d) and BALB.B (H2-b) mice are more capable than
most other strains to mount vigorous Th2 responses upon
immunization or infection, the molecular basis for this dif-
ference are not known. Although it is difficult to compare
the amounts of cytokines produced by TCR transgenic T
cells primed in vitro with those produced by polyclonal
populations of T cells primed in vivo, we found that the
levels of IFN-  and IL-5 produced in these two experi-
mental settings were quite similar (Fig. 2, A and C, right
panel). However, TCR transgenic T cells primed in vitro
with BALB/c DCs produced less IL-4 than polyclonal
populations of BALB/c T cells primed in vivo. This could
be due to the fact that CD4  T cells from BALB/c mice
have an intrinsic ability to produce IL-4 upon stimulation
(36). Indeed, previous studies have shown that CD4  T
cells from BALB/c and B10.D2 mice are different (8–10,
37, 38). However, it has not yet been possible to determine
whether these differences account for the unusual ability of
BALB/c mice to mount a Th2 response in vivo. Whatever
the response to this question, we focused on the non-T cell
compartment and showed that DCs from BALB/c and
BALB.B mice differ from those from B10.D2 and C57BL/
6 mice in their ability to polarize CD4  T cells in vitro.
Our results suggest that the intrinsic ability of different in-
dividuals to mount Th1- or Th2-dominated responses may
be governed by polymorphic genes which are expressed by
DCs. Identifying the molecular mechanisms which are at
work and the genes which are involved may be valuable for
understanding why some individuals are more susceptible
than others to specific infectious or autoimmune diseases.
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